
- Telehealth Visits
- Insurance plan information

Ashley Manchanda, DO
- Telehealth Visits
- Insurance plan information
Radiation Oncology Mount Zion



Ashley Manchanda, DO
Radiation Oncology Mount Zion
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Geriatric Medicine, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Geriatric Medicine, UCLA Med Ctr School of Medicine
- BS Women's Heart Center Clinical/Research Fellowship, Cedars-Sinai Medical Center GME
Residency
- Internal Medicine, Harbor / UCLA Medical Center
Internship
- Family Medicine, Harbor / UCLA Medical Center
Degree
- DO, Western University of Health Sciences
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%224762%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224762%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.